Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders

NCT06843044 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Anxiety
Neurasthenia
Adjustment Disorders

Interventions

DRUG: Ranquilon
DRUG: Afobazole

Sponsor

Valenta Pharm JSC